[Gyrase inhibitors modify metabolising processes in the liver].
作者信息
Staib A H, Harder S, Papenburg A, Stille W
出版信息
Dtsch Med Wochenschr. 1987 Oct 30;112(44):1720-1.
PMID:2822371
Abstract
摘要
相似文献
1
[Gyrase inhibitors modify metabolising processes in the liver].[回旋酶抑制剂改变肝脏中的代谢过程]
Dtsch Med Wochenschr. 1987 Oct 30;112(44):1720-1.
2
Gyrase-inhibitors impair caffeine elimination in man.
Methods Find Exp Clin Pharmacol. 1987 Mar;9(3):193-8.
3
[Resistance against new gyrase inhibitors--1985/86].
Dtsch Med Wochenschr. 1987 May 29;112(22):903-4.
4
5
[In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].新型喹诺酮类药物对非发酵菌的体外活性及敏感性试验参考
Infection. 1986;14 Suppl 3:S191-5. doi: 10.1007/BF01667842.
6
[In vitro antibacterial activity of new derivatives of pyridonecarboxylic acid, norfloxacin, ofloxacin, enoxacin and ciprofloxacin, against Vibrio cholerae O-1].吡啶酮羧酸新衍生物、诺氟沙星、氧氟沙星、依诺沙星和环丙沙星对霍乱弧菌O-1的体外抗菌活性
Kansenshogaku Zasshi. 1987 Mar;61(3):292-6. doi: 10.11150/kansenshogakuzasshi1970.61.292.
7
4-quinolones inhibit biotransformation of caffeine.4-喹诺酮类药物抑制咖啡因的生物转化。
Eur J Clin Pharmacol. 1988;35(6):651-6. doi: 10.1007/BF00637602.
8
Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.粘质沙雷氏菌对萘啶酸和吡哌酸耐药的变异株对环丙沙星、依诺沙星和诺氟沙星存在不完全交叉耐药性。
Chemotherapy. 1985;31(1):34-9. doi: 10.1159/000238311.
9
New synthetic quinolone antibacterial agents and serum concentration of theophylline.新型合成喹诺酮类抗菌剂与茶碱的血清浓度
Chest. 1987 Oct;92(4):663-9. doi: 10.1378/chest.92.4.663.
10
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].[棒状杆菌D2组。临床研究、生化鉴定及抗生素敏感性]
Pathol Biol (Paris). 1988 May;36(5):460-4.
引用本文的文献
1
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
Zotero 插件